InnoCan Pharma Corporation
INNO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -590.00K | -582.00K | -114.00K | -290.00K |
| Total Depreciation and Amortization | 11.00K | 9.00K | 10.00K | 6.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.11M | 664.00K | 917.00K | -444.00K | 878.00K |
| Change in Net Operating Assets | -153.00K | 603.00K | 23.00K | 48.00K | -1.60M |
| Cash from Operations | 22.00K | 686.00K | 368.00K | -504.00K | -1.00M |
| Capital Expenditure | -4.00K | -1.00K | -5.00K | -4.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1.00K | 1.00K | 69.00K | -- |
| Cash from Investing | -4.00K | -2.00K | -4.00K | 65.00K | -6.00K |
| Total Debt Issued | 0.00 | 0.00 | 640.00K | -- | -- |
| Total Debt Repaid | -3.00K | -4.00K | -4.00K | -6.00K | -6.00K |
| Issuance of Common Stock | 0.00 | 93.00K | -- | -- | 395.00K |
| Repurchase of Common Stock | -- | -- | -- | -123.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 64.00K | 360.00K | 529.00K | 470.00K |
| Cash from Financing | -3.00K | 153.00K | 996.00K | 400.00K | 859.00K |
| Foreign Exchange rate Adjustments | 0.00 | 53.00K | -3.00K | -10.00K | 18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.00K | 890.00K | 1.36M | -49.00K | -132.00K |